ARHGAP21 Inhibitors

The chemical class designated as ARHGAP21 inhibitors refers to compounds that can affect the activity of the ARHGAP21 protein. Since direct inhibitors of ARHGAP21 are not identified, the class involves chemicals that modulate the protein's activity indirectly through the interference of associated signaling pathways, such as the Rho/ROCK pathway. These compounds include small molecule inhibitors of Rho GTPases and their upstream regulators or downstream effectors. Some of these compounds are ROCK inhibitors like Y-27632 and Fasudil, which act by inhibiting Rho-associated protein kinase, a downstream effector in the Rho GTPase signaling pathway, leading to increased GTPase activity. Statins, widely known as cholesterol-lowering agents, also play a role in protein prenylation, a post-translational modification critical for the proper localization and function of Rho GTPases, hence potentially affecting ARHGAP21 activity.

Other molecules such as NSC23766, EHT 1864, ITX3, Rhosin, CCG-1423, ML141, CASIN, ZCL278, and SecinH3 target various aspects of the Rho GTPase signaling cascade. These chemicals can inhibit GEFs, modify gene transcription related to RhoA, or stabilize GTPases in their inactive states. These actions can influence the cellular processes controlled by ARHGAP21 indirectly, such as actin cytoskeleton organization, cell adhesion, migration, and proliferation. The identified compounds have varying degrees of specificity and efficacy in the modulation of Rho GTPase activity and, by extension, ARHGAP21's role in these pathways.